FDA recall D-0130-2019

RXQ Compounding LLC · Class II · drug

Product

Lidocaine 1% + Epinephrine 1:100,000 (MDV) INJ SOL, 50 mL per glass vial, Rx only, 340 West State Street, Unit 9, Athens, OH 45701. NDC 7073197450

Reason for recall

Subpotent drug: During testing of the retention sample, the firm discovered that the product was sub-potent.

Distribution

U.S.A. nationwide

Key facts

Status
Terminated
Initiation date
2018-09-25
Report date
2018-10-31
Termination date
2022-10-18
Voluntary/Mandated
Voluntary: Firm initiated
Location
Athens, OH, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0130-2019